Traws Pharma, Inc. (TRAW) Return on equity 2015–2022
Traws Pharma, Inc. (TRAW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-177.5%FY2022 · since FY2015: -457.7% → -177.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -177.5% | -110.6 pp |
| FY2021 | -67.0% | -31.9 pp |
| FY2020 | -35.0% | +372.4 pp |
| FY2019 | -407.4% | -221.6 pp |
| FY2018 | -185.8% | +196.1 pp |
| FY2017 | -381.9% | — |
| FY2015 | -457.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More TRAW financial trends
TRAW RevenueTRAW Net incomeTRAW Net marginTRAW Gross profitTRAW Gross marginTRAW Operating incomeTRAW Operating marginTRAW Operating cash flowTRAW Free cash flowTRAW Capital expendituresTRAW Stock buybacksTRAW Dividends paidTRAW Total assetsTRAW Total liabilitiesTRAW Shareholders’ equityTRAW overview →